Trump’s travel ban rattles medical residency programs
From the article:
Trump's order on regulations is a 'terrible idea' for rulemaking. That's according to law professor Rachel Sachs, who uses the 21st Century Cures Act — which passed Congress with bipartisan support — as an example of how Trump's order could backfire.
"The 'regulations' the FDA would issue under the Act — whether through notice-and-comment rulemaking or guidance — are not ones the agency in its own judgment has decided are necessary," Sachs writes at Harvard's "Bill of Health" blog. "Yet for every one of these new 'regulations,' this EO will require the agency to remove two prior regulations? This is a terrible idea."bioethics fda health law policy international pharmaceuticals rachel sachs regulation